SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Deoras Mukul

(Last) (First) (Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2015
3. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Marketing Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 46,454(1) D
Common Stock 6,358 I By Issuer's 401(k) Plan Trustee
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) 09/16/2011(2) 09/16/2016 Common Stock 20,400 38.29 D
Stock Option (Right to Buy) 09/08/2012(2) 09/08/2017 Common Stock 24,000 45.23 D
Stock Option (Right to Buy) 09/13/2013(2) 09/13/2018 Common Stock 34,000 52.27 D
Stock Option (Right to Buy) 09/12/2014(2) 09/12/2019 Common Stock 35,660 59.28 D
Stock Option (Right to Buy) 09/10/2015(3) 09/10/2020 Common Stock 44,866 64 D
Explanation of Responses:
1. All amounts reported in this Form 3 do not reflect the stock split of the issuer effective as of May 15, 2013.
2. Option became exercisable in one-third increments beginning on the first anniversary of the grant date.
3. Option becomes exercisable in one-third increments beginning on the first anniversary of the grant date.
Remarks:
/s/ Kristine Hutchinson, Attorney-in-Fact 07/07/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.